NXP Semiconductors, Brinker International, Ultra Clean, Sanmina And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga29minutes ago

Pfizer Hints at Acquisitions to Boost Obesity Pipeline After Trial Setback

Seeking Alpha07:23 ET

Regeneron Pharmaceuticals Q1 Adj. EPS $8.22 Misses $8.82 Estimate, Sales $3.03B Miss $3.29B Estimate

Benzinga06:30 ET

Earnings Scheduled For April 29, 2025

Benzinga04:32 ET

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

Benzinga03:57 ET

BEIGENE's revenue growth in 2024, narrowing losses, and core products gaining global traction.

① The company achieved a revenue of 27.214 billion yuan for the year, with a year-on-year increase of 56.19%; the net income attributable to shareholders was -4.978 billion yuan, a decrease of 17.38% from the previous year; the net income excluding non-recurring items was -5.379 billion yuan, a year-on-year decrease of 17.38%; ② The revenue share of Baiyueze and Baizean continues to expand, driving the company's revenue growth.

cls.cn21:53 ET